# A Study of LY2405319 in Participants With Type 2 Diabetes

> **NCT01869959** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 47 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** LY2405319
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01869959
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** 2009-06
- **Final completion:** 2009-12
- **Target enrollment:** 47 (ACTUAL)
- **Last updated:** 2017-03-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01869959

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01869959, "A Study of LY2405319 in Participants With Type 2 Diabetes". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01869959. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*